![Enterome starts Phase I clinical trial with its lead candidate EB8018 to treat Crohn’s disease](https://www.seventure.fr/wp-content/uploads/2016/11/4__104270789-1-322x211.jpg)
5 January 2017
Enterome starts Phase I clinical trial with its lead candidate EB8018 to treat Crohn’s disease
Enterome SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce the launch of a Phase 1 clinical study with its...